Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cue Biopharma, Inc. (CUE)  
$1.91 0.27 (12.39%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,500,000
Market Cap: 56.35(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.365 - $4.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cue Biopharma is a biopharmaceutical company engineering a class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body. Co. is focusing on drug product candidates for treating cancer in its CUE-100 series, which exploits rationally engineered interleukin 2, in context of the key Immuno- Selective Targeting and Alteration of T Cells framework for selective activation of targeted tumor-specific T cells. Co. is seeking third party support through partnerships and collaborations, or alternative funding structures, to further develop its programs outside of oncology, including its CUE-200, CUE-300 and CUE-400 series.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 7,000 240,000
Total Buy Value $0 $0 $19,620 $836,320
Total People Bought 0 0 2 4
Total Buy Transactions 0 0 2 5
Total Shares Sold 0 0 0 9,325
Total Sell Value $0 $0 $0 $30,586
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 112
  Page 4 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Marlett Christopher A Director   –       •      –    2019-12-27 4 S $17.24 $155,160 I/I (9,000) 775,203     -
   Marlett Christopher A Director   –       •      –    2019-12-26 4 S $17.53 $344,412 I/I (19,647) 784,203     -
   Marlett Christopher A Director   –       •      –    2019-12-23 4 S $16.82 $285,940 I/I (17,000) 803,850     -
   Marlett Christopher A Director   –       •      –    2019-12-19 4 S $17.00 $68,000 I/I (4,000) 820,850     -
   Marlett Christopher A Director   –       •      –    2019-12-17 4 S $15.73 $326,114 I/I (20,732) 824,850     -
   Marlett Christopher A Director   –       •      –    2019-12-12 4 A $0.00 $0 I/I 755,980 845,582     -
   Marlett Christopher A Director   –       •      –    2019-12-12 4 D $0.00 $0 I/I (1,007,973) 0     -
   Suri Anish President and CSO   •       –      –    2019-11-01 4 D $8.63 $104,311 D/D (12,087) 23,246     -
   Suri Anish President and CSO   •       –      –    2019-11-01 4 OE $0.00 $0 D/D 33,333 35,333     -
   Fletcher Aaron G.l. Director   –       •      –    2019-10-03 3 IO $0.00 $0 I/I 0 8,867     -
   Fletcher Aaron G.l. Director   –       •      –    2019-10-03 3 IO $0.00 $0 D/D 0 150,952     -
   Passeri Daniel R CEO and President   •       •      –    2019-06-21 4 B $7.26 $9,997 D/D 1,377 51,977 2.81     -
   Sandercock Colin SVP, General Counsel and Sec   •       –      –    2019-06-10 4/A B $7.90 $118,698 D/D 15,025 17,125 2.74     -
   Sandercock Colin SVP, General Counsel and Sec   •       –      –    2019-06-10 4 B $7.93 $118,458 D/D 14,938 16,938 2.74     -
   Sandercock Colin SVP, General Counsel and Sec   •       –      –    2019-06-07 4/A B $7.35 $735 D/D 100 2,100 2.66     -
   Sandercock Colin SVP, General Counsel and Sec   •       –      –    2019-06-06 4 B $7.10 $14,200 D/D 2,000 2,000 2.74     -
   Passeri Daniel R CEO and President   •       •      –    2019-06-06 4 B $6.90 $20,700 D/D 3,000 50,600 2.81     -
   Marlett Christopher A Director   –       •      –    2018-12-31 4 B $4.64 $85,937 I/I 18,521 89,602 2.1     -
   Digiandomenico Anthony Director   –       •      –    2018-12-28 4 B $4.62 $32,340 D/D 7,000 57,000 2.39     -
   Digiandomenico Anthony Director   –       •      –    2018-12-27 4 B $4.77 $95,400 D/D 20,000 50,000 2.39     -
   Marlett Christopher A Director   –       •      –    2018-12-26 4 B $4.29 $84,286 I/I 19,647 71,081 2.1     -
   Digiandomenico Anthony Director   –       •      –    2018-12-24 4 B $4.81 $48,100 D/D 10,000 30,000 2.39     -
   Digiandomenico Anthony Director   –       •      –    2018-12-21 4 B $4.49 $44,900 D/D 10,000 20,000 2.39     -
   Marlett Christopher A Director   –       •      –    2018-12-21 4 B $4.53 $77,916 I/I 17,200 51,434 2.1     -
   Suri Anish Chief Scientific Officer   •       –      –    2018-12-21 4 B $4.37 $8,740 D/D 2,000 2,000 2.74     -
  112 Records found
  1  2  3  4  5   
  Page 4 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us